GSK among top FTSE gainers after $370 mln mRNA patent settlement

CureVac NV

08/08/2025 08:20

** British drugmaker GSK GSK.L shares up 1.5% at 1,403.5p

** Stock among top percentage gainers on FTSE 100 index .FTSE

** Co to receive $370 mln upfront from CureVac, as part of mRNA patent settlement with Pfizer/BioNTech

** YTD, GSK stock up about 4.29%

 (Reporting by Judes Joseph in Bengaluru)

 ((judes.joseph@thomsonreuters.com;))